Verisante Technology Inc (VRSEF) 0.1250 $VRSEF
Verisante Technology, Inc. to Present at 2nd Global Life Sciences Conference in Warsaw and Announces Change in Board of Directors
Marketwire - Thu Sep 25, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, today announced that Thomas Braun, President & CEO will present at the upcoming 2nd Global Life Sciences Conference in Warsaw on October 2, 2014 at the trading floor of the Warsaw Stock Exchange, Warsaw, Poland.
Verisante Technology, Inc. Welcomes Dr. Kenneth Beer and Dr. Philip Werschler onto Clinical Advisory Board
Marketwire - Tue Jul 29, 9:02AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, is pleased to welcome Dr. Kenneth Beer, MD, PA and Dr. Wm. Philip Werschler, MD, FAAD, FAACS, onto the Company's Clinical Advisory Board.
Verisante Technology, Inc. Announces Non Brokered Private Placement and Letter of Intent for the Exclusive Sales and Marketing Rights for Cancer Detection Technology in China
Marketwire - Wed Jun 25, 8:31AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today it has closed a non-brokered private placement of 2,000,000 common shares at a price of $0.15 per share for gross proceeds of $300,000.
Verisante Technology's Early Cancer Detection Devices, CEO Clip Video
Newsfile Corp - Thu Mar 20, 10:01AM CDT
full story)
Verisante Completes Private Placement
Marketwire - Tue Mar 18, 12:04PM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS) (OTCQX: VRSEF) (the "Company" or "Verisante" , announced today that it has closed a non-brokered private placement of 2,827,000 units ("Units" at a price of $0.17 per Unit for gross proceeds of $480,590. Each Unit consists of one common share of the Company and one common share purchase warrant (a "Warrant" . Each Warrant entitles the holder to acquire a common share at a price of $0.25 for a period of 24 months from the date of issuance, subject to certain acceleration provisions contained within the warrant certificate.
Verisante Technology, Inc. Expands Intellectual Property Portfolio
Marketwire - Wed Mar 12, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today that the Chinese Patent Office has issued a decision to grant Patent Application No. 2006800074 entitled "Methods and Apparatus for Measuring Cancerous Changes from Reflectance Spectral Measurements Obtained During Endoscopy Imaging".
Verisante Technology, Inc. Grows Sales and Marketing Team
Marketwire - Wed Feb 26, 9:02AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today that the Company has hired Jason Mangler as Director of Sales to guide the Company's world-wide sales and marketing strategy. Verisante has also hired Kim Ellis, as the Company's Sales Representative for Western Canada.
Launch: Ericsson brings capacity with 'Small Cell as a Service'
M2 - Thu Feb 13, 7:16AM CST
- Enables increased network capacity in environments where large numbers of people gather and consume large amounts of data
Verisante Technology, Inc. Launches New Product at SPIE Photonics West 2014 in San Francisco, CA
Marketwire - Tue Feb 04, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today that the Company is launching a new product at the SPIE Photonics West 2014 industry exhibit in San Francisco, California from February 4-6, 2014. Photonics West is the annual flagship event for the optics and photonics industry, with 20,000 attendees expected to attend.
A.M. Best Affirms Ratings of LocalTapiola General Mutual Insurance Company
A.M. Best Company - AMBest - Fri Jan 17, 10:41AM CST
A.M. Best Europe â?? Rating Services Limited has affirmed the financial strength rating of A (Excellent) and issuer credit rating of â??aâ? of LocalTapiola General Mutual Insurance Company (LocalTapiola) (Finland). The outlook for both ratings remains stable.
Verisante Technology, Inc. Files Preliminary Short Form Base Shelf Prospectus
Newsfile Corp - Fri Sep 13, 6:12PM CDT
full story)
Verisante Technology, Inc. Announces Completion of Prototype of Multispectral Imaging System for Skin Cancer
Marketwire - Tue Sep 10, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today that the Company has completed the second phase prototype of a rapid Multispectral Imaging ("MSI" System for skin cancer detection.
Verisante Technology, Inc. Announces 2013 Second Quarter Results and Reports on Progress with Core Device for Lung, Colon and Nasopharyngeal Cancer
Marketwire - Fri Aug 30, 8:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today that the Company has released its financial results for the second quarter ended June 30, 2013 .
Verisante Technology, Inc. to Present at 2nd Global Life Sciences Conference in Warsaw and Announces Change in Board of Directors
Marketwire - Thu Sep 25, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, today announced that Thomas Braun, President & CEO will present at the upcoming 2nd Global Life Sciences Conference in Warsaw on October 2, 2014 at the trading floor of the Warsaw Stock Exchange, Warsaw, Poland. Verisante Technology, Inc. Welcomes Dr. Kenneth Beer and Dr. Philip Werschler onto Clinical Advisory Board
Marketwire - Tue Jul 29, 9:02AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, is pleased to welcome Dr. Kenneth Beer, MD, PA and Dr. Wm. Philip Werschler, MD, FAAD, FAACS, onto the Company's Clinical Advisory Board. Verisante Technology, Inc. Announces Non Brokered Private Placement and Letter of Intent for the Exclusive Sales and Marketing Rights for Cancer Detection Technology in China
Marketwire - Wed Jun 25, 8:31AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today it has closed a non-brokered private placement of 2,000,000 common shares at a price of $0.15 per share for gross proceeds of $300,000. Verisante Technology's Early Cancer Detection Devices, CEO Clip Video
Newsfile Corp - Thu Mar 20, 10:01AM CDT
full story)
Verisante Completes Private Placement
Marketwire - Tue Mar 18, 12:04PM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS) (OTCQX: VRSEF) (the "Company" or "Verisante"
, announced today that it has closed a non-brokered private placement of 2,827,000 units ("Units" at a price of $0.17 per Unit for gross proceeds of $480,590. Each Unit consists of one common share of the Company and one common share purchase warrant (a "Warrant" . Each Warrant entitles the holder to acquire a common share at a price of $0.25 for a period of 24 months from the date of issuance, subject to certain acceleration provisions contained within the warrant certificate. Verisante Technology, Inc. Expands Intellectual Property Portfolio
Marketwire - Wed Mar 12, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Chinese Patent Office has issued a decision to grant Patent Application No. 2006800074 entitled "Methods and Apparatus for Measuring Cancerous Changes from Reflectance Spectral Measurements Obtained During Endoscopy Imaging". Verisante Technology, Inc. Grows Sales and Marketing Team
Marketwire - Wed Feb 26, 9:02AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Company has hired Jason Mangler as Director of Sales to guide the Company's world-wide sales and marketing strategy. Verisante has also hired Kim Ellis, as the Company's Sales Representative for Western Canada. Launch: Ericsson brings capacity with 'Small Cell as a Service'
M2 - Thu Feb 13, 7:16AM CST
- Enables increased network capacity in environments where large numbers of people gather and consume large amounts of data
Verisante Technology, Inc. Launches New Product at SPIE Photonics West 2014 in San Francisco, CA
Marketwire - Tue Feb 04, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Company is launching a new product at the SPIE Photonics West 2014 industry exhibit in San Francisco, California from February 4-6, 2014. Photonics West is the annual flagship event for the optics and photonics industry, with 20,000 attendees expected to attend. A.M. Best Affirms Ratings of LocalTapiola General Mutual Insurance Company
A.M. Best Company - AMBest - Fri Jan 17, 10:41AM CST
A.M. Best Europe â?? Rating Services Limited has affirmed the financial strength rating of A (Excellent) and issuer credit rating of â??aâ? of LocalTapiola General Mutual Insurance Company (LocalTapiola) (Finland). The outlook for both ratings remains stable.
Verisante Technology, Inc. Files Preliminary Short Form Base Shelf Prospectus
Newsfile Corp - Fri Sep 13, 6:12PM CDT
full story)
Verisante Technology, Inc. Announces Completion of Prototype of Multispectral Imaging System for Skin Cancer
Marketwire - Tue Sep 10, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Company has completed the second phase prototype of a rapid Multispectral Imaging ("MSI" System for skin cancer detection. Verisante Technology, Inc. Announces 2013 Second Quarter Results and Reports on Progress with Core Device for Lung, Colon and Nasopharyngeal Cancer
Marketwire - Fri Aug 30, 8:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Company has released its financial results for the second quarter ended June 30, 2013 . 
